articleThe LancetAug 1, 2003Closed access

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

PSPierre‐Yves ScarabinEOEmmanuel OgerGPGeneviève Plu‐Bureau

Inserm · Hôpital Maison Blanche

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

709
total citations
FWCI
31.34
Percentile
100%
References
26
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • Medicine
  • Transdermal
  • Odds ratio
  • Venous thrombosis
  • Confounding
  • Internal medicine
  • Hormone replacement therapy (female-to-male)
  • Thrombosis
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding